Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medicago Inc MDCGF

GREY:MDCGF - Post Discussion

Medicago Inc > Good news...indeed
View:
Post by Jentai on Dec 05, 2011 3:36pm

Good news...indeed


UPDATE 1-RBC starts Medicago with outperform,shares up4 hours ago by Thomson Reuters
* Starts coverage with"outperform", target price C$1.25
* Shares up 9 pct (Follows alerts)
Dec 5 (Reuters) - RBC Capital Marketsinitiated coverage on Medicago Inc with an "outperform" rating and aprice target of C$1.25, citing the Canadian biotechnology company's faster andlow-cost approach to producing influenza vaccines.
Shares of the company were up more than 9percent in early trade on Monday.
Medicago, which produces pandemic andseasonal flu vaccines from plants such as tobacco leaves, uses its technologyto produce particles that resemble a virus, but are non-infectious and cannotreplicate.
"Compared with other incumbents, whichprimarily employ chicken eggs to make vaccines and require 12-20 weeks,Medicago's vaccines can be made in 4-6 weeks and at a fraction of thecost," said RBC Capital Markets in a note.
These speed and cost advantages are importantfactors for governments to consider while preparing for pandemic outbreaks, thebrokerage added.
In June, the company had said it expects tohave the capacity to commercially produce its experimental bird flu vaccines asits facility in North Carolina which will be operational this fall.
Shares ofthe Quebec City-based company were trading at 58 Canadian cents on Monday onthe Toronto Stock Exchange. (Reporting by Maneesha Tiwari in Ban
Comment by rocket65 on Dec 05, 2011 6:24pm
RBC is a little more solid than other billybob and hillbillybob analysts. RBC has there share of profesional sector based analysts. There biotech folks are half decent. Of course, this does not mean they will outperform. But now RBC has coverage, that's actually pretty good. They are barely a small cap, but...??Forge ahead, and go where no man (or woman) has ever gone before. And that's ...more  
Comment by blitzer2 on Dec 05, 2011 6:59pm
Yep I agree, whatever. I`ll take it anyway and let's see if we can sustain a few days of this kind of volume for a change. The last time we did that was the first week in July, and we reached a high of .74 GLTA
Comment by Jentai on Dec 05, 2011 8:46pm
I agree RBC analysts are solid not a self-serving bunch like Paradigm...not in the same class. I look forward to tomorrow...we might go up...we might go down. On all the stocks reviews on the release this morning, MDG is the only one rated as outperform...not a bad sign coming from RBC
Comment by beenthere on Dec 05, 2011 9:32pm
To H*ll with analysts!MDG could rise on it's own meritsIF it wasn't for the games being played!Jentai, have fairchij and you made any  progress?Post here or pm meThanks!
Comment by rocket65 on Dec 06, 2011 8:16am
YOu can have the best toaster in the world, no questions asked. But if you don't have a sales guy and marketing, then all you have is a toaster. But in this case medicago has partnered with a big toaster company who obviously likes how the toast looks.Enough analogies. A big pharma partner, some $$ in the bank. A product that looks promising. I'm also excited about the H1N1 pipeline. That ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities